首页> 外文期刊>Clinical Chemistry >Reference Population and Marathon Runner Sera Assessed by Highly Sensitive Cardiac Troponin T and Commercial Cardiac Troponin T and I Assays
【24h】

Reference Population and Marathon Runner Sera Assessed by Highly Sensitive Cardiac Troponin T and Commercial Cardiac Troponin T and I Assays

机译:高敏感性心肌肌钙蛋白T和商业性心肌肌钙蛋白T和I分析评估的参考人群和马拉松运动员血清

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Endurance exercise can increase cardiac troponin (cTn) concentrations as high as those seen in cases of minor myocardial infarction. The inability of most cTn assays to reliably quantify cTn at very low concentrations complicates a thorough data analysis, and the clinical implications of such increases remain unclear. The application of recently developed highly sensitive cTn immunoassays may help resolve these problems. We evaluated the precommercial highly sensitive cardiac troponin T (hs-cTnT) assay from Roche Diagnostics and the Architect cardiac troponin I (cTnI-Architect) assay from Abbott Diagnostics by testing samples from a reference population of 546 individuals and a cohort of 85 marathon runners. We also measured the samples with the current commercial cTnT assay for comparison. Although the hs-cTnT and cTnI-Architect assays were capable of measuring cTn concentrations at low concentrations (<0.01 µg/L), only the hs-cTnT assay demonstrated a CV of <10% at the 99th percentile of the reference population and a near-gaussian distribution of the measurements. After a marathon, 86% of the runners had cTnT concentrations greater than the 99th percentile with the hs-cTnT assay, whereas only 45% of the runners showed increased concentrations with the current cTnT assay. cTn concentrations remained significantly increased the day after the marathon. A multiple regression analysis demonstrated marathon experience and age to be significant predictors of postmarathon cTn concentrations (P < 0.05). The hs-cTnT assay was the only assay tested with a performance capability sufficient to detect cTn concentrations in healthy individuals. The number of runners with increased cTn concentrations after a marathon depends highly on an assay's limit of detection (LOD). The assay with the lowest LOD, the hs-cTnT assay, showed that almost all runners had increased cTn concentrations. The clinical implications of these findings require further investigation.
机译:耐力运动可以使心肌肌钙蛋白(cTn)的浓度增加,与轻度心肌梗死时一样。大多数cTn分析无法在非常低的浓度下可靠地定量cTn,这使得彻底的数据分析变得复杂,而且这种增加的临床意义仍不清楚。最近开发的高度敏感的cTn免疫测定的应用可能有助于解决这些问题。我们通过测试来自546个人的参考人群和一组85位马拉松运动员的样本,评估了Roche Diagnostics的商业前高度敏感的心肌肌钙蛋白T(hs-cTnT)分析和Abbott Diagnostics的Architect心脏肌钙蛋白I(cTnI-Architect)分析。我们还使用当前的商用cTnT测定法测量了样品以进行比较。尽管hs-cTnT和cTnI-Architect分析法能够在低浓度(<0.01 µg / L)下测量cTn浓度,但只有hs-cTnT分析法显示在参考人群的第99个百分位数时CV <10%。测量值接近高斯分布。马拉松后,通过hs-cTnT分析,有86%的跑步者的cTnT浓度高于第99个百分点,而在当前的cTnT分析中,只有45%的跑步者显示出更高的浓度。马拉松比赛后第二天,cTn浓度仍显着增加。多元回归分析表明,马拉松经验和年龄是马拉松后cTn浓度的重要预测指标(P <0.05)。 hs-cTnT测定法是唯一测试的具有足以检测健康个体中cTn浓度的性能的测定法。马拉松后cTn浓度升高的跑步者数量在很大程度上取决于测定的检测极限(LOD)。具有最低LOD的分析hs-cTnT分析表明,几乎所有跑步者的cTn浓度均升高。这些发现的临床意义需要进一步研究。

著录项

  • 来源
    《Clinical Chemistry》 |2009年第1期|p.101-108|共8页
  • 作者单位

    Alma Mingels,1 Leo Jacobs,1 Etienne Michielsen,2 Joost Swaanenburg,2 Will Wodzig,1 and Marja van Dieijen-Visser1*1 Department of Clinical Chemistry, University Hospital Maastricht, Maastricht, the Netherlands, 2 Department of Clinical Chemistry and Haematology, VieCuri Medical Center, Venlo, the Netherlands.* Address correspondence to this author at: Department of Clinical Chemistry, University Hospital Maastricht, P.O. Box 5800, 6202 AZ Maastricht, the Netherlands. Fax +31-43-3874692, e-mail dieijen@klinchem.azm.nl.Received March 7, 2008, accepted October 13, 2008.Previously published online at DOI: 10.1373/clinchem.2008.106427,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号